Cargando…
The Mounting Evidence for Permissive Hypercreatinemia in Acute Heart Failure: Adding Sodium Glucose Cotransporter Inhibitors to the List
Autores principales: | Macedo, Etienne, Wettersten, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617792/ https://www.ncbi.nlm.nih.gov/pubmed/37883999 http://dx.doi.org/10.34067/KID.0000000000000266 |
Ejemplares similares
-
Sodium-glucose cotransporter 2 inhibitors’ mechanisms of action in heart failure
por: Grubić Rotkvić, Petra, et al.
Publicado: (2020) -
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure
por: Dutka, Mieczysław, et al.
Publicado: (2020) -
Sodium-glucose cotransporter 2 inhibitors in obese patients with heart failure
por: Kato, Shingo, et al.
Publicado: (2023) -
Sodium-glucose cotransporter 2 inhibitors in Asian patients with heart failure
por: Kato, Shingo, et al.
Publicado: (2023) -
Clinical Characterization and Outcomes of Patients with Hypercreatinemia Affected by COVID-19
por: Elkhalifa, Ahmed M. E., et al.
Publicado: (2023)